GM
65
-7
MMC
67
2
FFIV
69
2
MUR
42
-2
CMCSA
48
-2
WY
60
-2
INTU
56
3
GRMN
67
-3
UPS
61
-3
CVX
46
8
SJM
45
9
XOM
40
-7
VRSK
82
2
JWN
59
2
URBN
50
-2
INTC
40
-4
GME
70
2
NWL
54
-3
VRSN
58
2
PPG
61
-4
GM
65
-7
MMC
67
2
FFIV
69
2
MUR
42
-2
CMCSA
48
-2
WY
60
-2
INTU
56
3
GRMN
67
-3
UPS
61
-3
CVX
46
8
SJM
45
9
XOM
40
-7
VRSK
82
2
JWN
59
2
URBN
50
-2
INTC
40
-4
GME
70
2
NWL
54
-3
VRSN
58
2
PPG
61
-4
Financhill
Back

Amedisys Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
56

AMED
Amedisys

Last Price:
91.22
Seasonality Move:
12.33%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
136.77
Seasonality Move:
14.88%
Buy
56
Amedisys (AMED) is a Buy

Is Amedisys a Buy, Sell or Hold?

  • The current Amedisys [AMED] share price is $91.02. The Score for AMED is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • AMED is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AMED Stock Price Chart

What is Amedisys's stock price today?

  • The Amedisys share price today is $91.02
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AMED is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

AMED Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.56 Sell
Relative Strength Index (14 RSI): 36.12 Sell
Chaikin Money Flow: 67304 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (90.54 - 96.46) Sell
Bollinger Bands (100): (94.11 - 98.73) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

AMED Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 90.29 Buy
20-day SMA: 92.74 Sell
50-day SMA: 95.11 Sell
200-day SMA: 94.75 Sell
8-day EMA: 90.86 Buy
20-day EMA: 92.29 Sell
50-day EMA: 94.27 Sell
200-day EMA: 94.92 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

Amedisys Earnings Growth & AMED Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and an increase next year of $0.56 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

Amedisys Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):